FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway US$ 23.88 ★★★★★ 4.6 (12 reviews)
Development of a novel senolytic by precise disruption of FOXO4-p53 complex US$ 28.07 ★★★★★ 4.5 (16 reviews)
Mechanisms of action of senolytic drugs targeting pro-survival pathways US$ 28.46 ★★★★★ 4.6 (10 reviews)
FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness US$ 28.58 ★★★★★ 4.7 (9 reviews)
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment US$ 21.98 ★★★★★ 4.8 (5 reviews)
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging US$ 21.10 ★★★★★ 4.3 (22 reviews)
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 22.63 ★★★★★ 4.8 (20 reviews)
FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation US$ 27.28 ★★★★★ 4.6 (10 reviews)
FOXO4-DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) US$ 27.54 ★★★★★ 4.0 (7 reviews)
Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics US$ 26.61 ★★★★★ 4.0 (22 reviews)
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells US$ 28.49 ★★★★★ 4.4 (6 reviews)
Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis US$ 21.95 ★★★★★ 4.3 (19 reviews)
Cagrilintide Weight Loss Results: What Patients in Louisiana Need to Know US$ 22.65 Min. order: 1 piece ★★★★★ 4.7 (18 reviews) Sold : Login>>
CagrisSema is a once-weekly injection of semaglutide and cagrilintide. Phase 2 clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising US$ 29.56 Min. order: 1 piece ★★★★★ 4.0 (26 reviews) Sold : Login>>
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr US$ 24.68 Min. order: 1 piece ★★★★★ 4.9 (23 reviews) Sold : Login>>
Is BPC‑157 a Risk? Safety, Side Effects, and Concerns Explained US$ 29.50 Min. order: 1 piece ★★★★★ 4.5 (16 reviews) Sold : Login>>
Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides – Holt Law US$ 23.03 Min. order: 1 piece ★★★★★ 4.6 (27 reviews) Sold : Login>>
A new drug combo of semaglutide (GLP-1 receptor agonist) with cagrilintide (amylin analogue) failed to do as well as tirzepatide (GLP-1/GIP receptor agonist). The future of these medicines is hitting different receptors US$ 26.09 Min. order: 1 piece ★★★★★ 4.8 (6 reviews) Sold : Login>>